Summary
The purpose of this study was to ascertain whether the pituitary-adrenal responses to human corticotropin-releasing hormone (hCRH) in “non-functioning” adrenocortical adenoma would uncover a functional activity in these adrenal nodules. Eleven patients with incidentally discovered “silent” adrenocortical adenoma and eleven controls were studied. The initial clinical and laboratory examination, including an overnight 1 mg dexamethasone suppression test, revealed no abnormalities in any of the subjects. IR-ACTH and serum steroids (F, S, P, 17OHP, 18OHB, and aldosterone) were normal in both controls and patients. After pulse IV injection of 100 νg hCRH, the cortisol response was significantly exaggerated (P=0.01). Stimulated plasma ACTH levels were, however, significantly lower in patients than in controls (P=0.01), indicating counter-feedback regulation of cortisol. The peak cortisol/peak ACTH ratio (Fmax/ACTHmax) in the patients was significantly elevated (26.8±4.37 nmol/ng vs. 14.6±2.16 nmol/ ng,P=0.02). Two further patients with incidentally discovered “pre-Cushing's” adrenocortical adenoma displayed an even higher ratio (43.5 and 45.5 nmol/ng). In established Cushing's syndrome due to an autonomous adrenocortical adenoma, suppression of ACTH and of the ACTH response to hCRH occurs with a very high basal cortisol/ basal ACTH ratio. Our findings suggest some functional activity even in clinically “silent” adrenocortical adenoma. Response to hCRH uncovers a continuous spectrum between adrenocortical adenoma, “pre-Cushing's”, and Cushing's syndrome.
Similar content being viewed by others
Abbreviations
- ACA:
-
adrenocortical adenoma
- ACTH:
-
adrenocorticotropin
- DHEAS:
-
Dehydroepiandrosterone sulfate
- F:
-
cortisol
- hCRH:
-
human corticotropin releasing hormone
- P:
-
progesterone
- S:
-
11-deoxycortisol
- 17OHP:
-
17-hydroxyprogesterone
- 18OHB:
-
18-hydroxy-corticosterone
References
Belmega W, Oelkers W, Belkien L, Shirpai M, Fiedler U, Häring R (1983) Effects of angiotensin II and ACTH on normal and tumorours human adrenocortical cells. Acta Endocrinol (Copenh) 104:103–109
Bertagna C, Orth DN (1981) Clinical and laboratory findings and results of therapy in 58 patients with adrenocortical tumors admitted to a single medical center (1951 to 1978). Am J Med 71:855–875
Beyer HS, Doe RP (1986) Cortisol secretion by an incidentally discovered nonfunctional adrenal adenoma. J Clin Endocrinol Metab 62:1317–1321
Bogner U, Eggens U, Hensen J, Oelkers W (1986) Incidentally discovered ACTH-dependent adrenal adenoma presenting as “pre-Cushing's syndrome”. Acta Endocrinol (Copenh) 111:89–92
Cavagnini F, Invitti C, Passamonti M, Polli EE (1986) Response of ACTH and cortisol to corticotropin-releasing hormone in anorexia nervosa. N Engl J Med 314:184–185
Charbonnel B, Chatal JF, Ozanne P (1986) Does the corticoadrenal adenoma with “pre-Cushing's syndrome” exist? J Nucl Med 22:1059–1061
Chrousos GP, Schulte HM, Oldfield EH, Gold PW, Cutler GB, Loriaux DL (1984) The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. N Engl J Med 310:622–626
Copeland PM (1983) The incidentally discovered adrenal mass. Ann Intern Med 98:940–945
Crapo L (1979) Cushing's syndrome: a review of diagnostic tests. Metabolism 28:955–977
D'Agata R, Malozowski S, Barkan A, Cassorla F, Loriaux D (1987) Steroid biosynthesis in human adrenal tumors. Horm Metabol Res 19:386–388
Fehm HL, Holl R, Späth-Schwalbe E, Born J, Voigt KH (1988) Ability of corticotropin-releasing hormone to stimulate cortisol secretion independent from pituitary adrenocorticotropin. Life Sciences 42:679–686
Geelhoed GW, Druy EM (1982) Management of the adrenal “incidentaloma”. Surgery 92:866–874
Genazzani AR, Facchinetti F, Pintor C, Puggioni R, Parrini D, Petraglia F, Bagnoli F, Corda R (1983) Proopiocortin-related peptide plasma levels throughout prepuberty and puberty. J Clin Endocrinol Metab 57:56–61
Glazer HS, Weyman PJ, Sagel SS, Levitt RG, McClennan BL (1982) Nonfunctioning adrenal masses: incidental discovery on computed tomography. AJR 139:81–85
Gold PW, Gwirtsman H, Avgerinos PC, Nieman LK, Gallucci WT, Kaye W, Jimerson D, Ebert M, Rittmaster R, Loriaux D, Chrousos GP (1986) Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. N Engl J Med 314:1335–1342
Hauser H, Battikha JG, Wettstein P (1981) Pathology of the adrenal glands: common and uncommon findings in computed tomography. Europ J Radiol 1:215–226
Hedeland H, Ostberg G, Hökfelt B (1968) On the prevalence of adrenocortical adenomas in autopsy material in relation to hypertension and diabetes. Acta Med Scand 184:211–214
Hensen J, Hader O, Bähr V, Oelkers W (1988) Effects of incremental infusions of arginine vasopressin on adrenocorticotropin and Cortisol secretion in man. J Clin Endocrinol Metab 66:668–671
Hermus AR, Pieters GF, Smals AG, Benraad TJ, Kloppenborg PW (1984) Plasma adrenocorticotropin, cortisol, and aldosterone responses to corticotropin-releasing factor: modulatory effect of basal cortisol levels. J Clin Endocrinol Metab 58:187–191
Huebener KH, Treugut H (1984) Adrenal cortex dysfunction: CT findings. Radiology 150:195–199
Inoue J, Sato T, Ooishi S, Iwaoka T, Oono M, Umeda T (1988) An incidentally discovered case of Cushing's syndrome without clinical signs. Endocrinol Jpn 35:371–378
Kater CE, Biglieri EG, Brust N, Chang B, Hirai J (1982) Zona fasciculata origin of 18-Hydroxycorticosterone in the chronically suppressed zona glomerulosa. J Clin Endocrinol Metab 55:628–633
Mitnick JS, Bosniak MA, Megibow AJ, Naidich DP (1983) Non-functioning adrenal adenomas discovered incidentally on computed tomography. Radiology 148:495–499
Molz L, Schwarz U, Sörensen R, Pickartz H, Hammerstein J (1984) Ovarian and adrenal vein steroids in patients with non-neoplastic hyperandrogenism: selective catheterization findings. Fertil Steril 42:69–75
Müller OA, Stalla GK, v. Werder K (1983) Corticotropin releasing factor: a new tool for the differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 57:227–229
Oelkers W, Kleiner S, Bähr V (1988) Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin, and blood pressure in humans. Hypertension 12:462–467
Pavlov EP, Harman SM, Chrousos GP, Lorioux DL, Blackman MR (1986) Responses of plasma adrenocorticotropin, cortisol, and dehydroepiandrosterone to ovine corticotropin-releasing hormone in healthy aging men. J Clin Endocrinol Metab 62:767–772
Prinz RA, Brooks MH, Churchill R, Graner JL, Lawrence AM, Paloyan E, Sparagana M (1982) Incidental asymptomatic adrenal masses detected by computed tomographic scanning: is operation required? JAMA 248:701–704
Ridgway EC, Weintraub BD, Cevallos JL, Rack MC, Maloof F (1973) Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest 52:2783–2792
Schöneshöfer M (1977) Simultaneous determination of eight adrenal steroids in human serum by radioimmunoassay. J Steroid Biochem 8:995–1009
Taylor AL, Fishman LM (1988) Corticotropin-releasing hormone. N Engl J Med 319:213–22
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hensen, J., Buhl, M., Bähr, V. et al. Endocrine activity of the “silent” adrenocortical adenoma is uncovered by response to corticotropin-releasing hormone. Klin Wochenschr 68, 608–614 (1990). https://doi.org/10.1007/BF01660959
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01660959